Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcom...
Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy
About this item
Full title
Author / Creator
Völter, Friederike , Mittlmeier, Lena , Gosewisch, Astrid , Brosch-Lenz, Julia , Gildehaus, Franz Josef , Zacherl, Mathias Johannes , Beyer, Leonie , Stief, Christian G. , Holzgreve, Adrien , Rübenthaler, Johannes , Cyran, Clemens C. , Böning, Guido , Bartenstein, Peter , Todica, Andrei and Ilhan, Harun
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Background: Dosimetry can tailor prostate-specific membrane-antigen-targeted radioligand therapy (PSMA-RLT) for metastatic castration-resistant prostate cancer (mCRPC). However, whole-body tumor dosimetry is challenging in patients with a high tumor burden. We evaluate a simplified index-lesion-based single-photon emission computed tomography (SPEC...
Alternative Titles
Full title
Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9465067559e145b7ba908c6f40a7d0fb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9465067559e145b7ba908c6f40a7d0fb
Other Identifiers
ISSN
2075-4418
E-ISSN
2075-4418
DOI
10.3390/diagnostics11030428
